Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
BMC Nephrol ; 24(1): 152, 2023 05 30.
Artículo en Inglés | MEDLINE | ID: mdl-37254087

RESUMEN

BACKGROUND: Recent studies have shown that donor nephrectomy can induce renal function impairment. However, few meta-analysis studies about this have proceeded. Therefore, the objective of this systematic review and meta-analysis including all data of recent research studies was to determine whether living donor nephrectomy (LDN) could induce renal function impairment. METHODS: By November 2020, comprehensive literature searches were performed on PubMed, Embase, and Cochrane databases. Inclusion criteria were: (1) observational studies with data about overall end-stage renal disease (ESRD) or chronic kidney disease (CKD) of living kidney donors, (2) control group consisted of people without donor nephrectomy, and (3) outcomes of studies included long-term end-stage renal disease risks after living kidney donation. Risk of Bias in Non-randomized Studies of interventions (ROBINS-I) assessment tool was used to evaluate our methodological quality. RESULTS: The qualitative review included 11 studies and the meta-analysis included 5 studies. In the meta-analysis, the integrated overall ESRD risk was 5.57 (95% CI: 2.03-15.30). Regarding the overall risk of bias using ROBINS-I assessment tool, 0 studies was rated as "Low", 7 studies were rated as "moderate", 2 studies were rated as "Serious", and two studies were rated as "Critical". CONCLUSIONS: Our study showed that LDN increased ESRD risk in LDN patients. However, in our meta-analysis, variables in included studies were not uniform and the number of included studies was small. To have a definite conclusion, meta-analyses of well-planned and detailed studies need to be conducted in the future.


Asunto(s)
Fallo Renal Crónico , Trasplante de Riñón , Insuficiencia Renal , Humanos , Trasplante de Riñón/efectos adversos , Nefrectomía/efectos adversos , Riñón/fisiología , Fallo Renal Crónico/epidemiología , Fallo Renal Crónico/cirugía , Donadores Vivos
2.
Clin Genitourin Cancer ; 22(1): e53-e65.e1, 2024 02.
Artículo en Inglés | MEDLINE | ID: mdl-37598012

RESUMEN

PURPOSE: To conduct systematic review and meta-analysis to evaluate effects of neoadjuvant chemotherapy (NAC) on survival and histopathological outcomes of variant histology (VH) of urothelial carcinoma (UC) of bladder. METHODS: This systematic review was registered in PROSPERO (CRD42023389115). Literature search was conducted in PubMed/Medline, Embase, and Cochrane Library for studies published up to January 2023. Population, intervention, comparator, outcome, and study design were as follows: bladder cancer patients with VH (population), neoadjuvant chemotherapy (intervention), radical cystectomy only (comparators), oncological survival and pathologic response (outcomes), and retrospective or prospective (study design). RESULTS: Finally, a total of 17 studies were included in the present study (quantitative analysis, n = 17; qualitative analysis, n = 12). Pooled HR was 0.49 (95% CI: 0.31-0.76; P = .002) for OS. Pooled HR was 0.61 (95% CI: 0.38-0.98; P = .04) for CSS. Pooled HR was 0.44 (95% CI: 0.21-0.93; P = .03) in PFS. Pooled OR was 6.61 (95% CI: 4.50-9.73; P < .00001) in complete pathologic response. Pooled OR was 9.59 (95% CI: 3.56-25.85; P < .00001) in any pathologic response. Evidence quality assessments for each 5 comparisons using the GRADE approach were that Certainty was moderate in 1, low in 1, and very low in 3. CONCLUSIONS: Administration of NAC before surgery in bladder cancer patients with VH might confer better survival outcomes and higher pathologic down staging rate than no administration of NAC before surgery.


Asunto(s)
Carcinoma de Células Transicionales , Neoplasias de la Vejiga Urinaria , Humanos , Neoplasias de la Vejiga Urinaria/tratamiento farmacológico , Neoplasias de la Vejiga Urinaria/cirugía , Vejiga Urinaria/patología , Carcinoma de Células Transicionales/tratamiento farmacológico , Cistectomía , Terapia Neoadyuvante/efectos adversos , Estudios Retrospectivos , Estudios Prospectivos , Respuesta Patológica Completa , Músculos/patología , Quimioterapia Adyuvante
3.
World J Clin Cases ; 11(18): 4306-4312, 2023 Jun 26.
Artículo en Inglés | MEDLINE | ID: mdl-37449221

RESUMEN

BACKGROUND: Testicular torsion is an emergent disease in urology, and there has been discussion of the treatment of testicular torsion. Testicular decompression has been established as a critical treatment for testicular compartment syndrome (TCS), which occurs after detorsion in a patient who is diagnosed with testis torsion. Until now, testicular fasciotomy and incision of tunica albuginea with tunica vaginalis flap (TVF) graft have been suggested for decompression, and some studies about the efficacy of TVF were reported. However, this method is time consuming and needs meticulous technique, so other methods such as orchio-septopexy are suggested. The objective of this clinical case report was to propose new surgical method using collagen fleece (Tachosil®) instead of tunica vagina flap. CASE SUMMARY: A 5-year-old boy with scrotal pain visited our hospital 24 h after symptom onset. After history taking, physical examination, and scrotum ultrasonography, he was diagnosed with testis torsion. Emergency surgery was performed after diagnosis. Following the incision of scrotum and fasciotomy, we covered his tunica albuginea with collagen fleece called Tachosil® instead of covering with TVF. CONCLUSION: Short-term follow-up showed normal blood flow in testis without a TCS. This is the first case report of using Tachosil® in testicular torsion surgery, and its advantages were already reported in other surgeries like Peyronie's disease. Our case suggests this new technique is an appropriate method because of its advantages including its cost-effective and time-saving characteristics. The main limitation is the short follow-up, so more studies are needed to provide a high level of evidence about its efficacy and safety.

4.
Int J Rehabil Res ; 46(4): 308-315, 2023 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-37678148

RESUMEN

This retrospective study aimed to predict dexterity at 3 and 6 months post-stroke by integrating clinical, neurophysiological, and neuroimaging factors. We included 126 patients with first-ever, unilateral, and supratentorial stroke. Demographic, stroke characteristics, and initial clinical assessment variables [Mini-mental state examination and Fugl-Meyer Assessment Upper Extremity (FMA-UE)] were evaluated 2 weeks after stroke. Dexterity, measured using the Manual Function Test (MFT) hand subscore, was the primary outcome. The neurophysiological variables, upper limb somatosensory evoked potential (SEP) and motor evoked potential (MEP), were assessed 2 weeks post-stroke. The neuroimaging variable, fractional anisotropy (FA) of the corticospinal tract (CST), was assessed 3 weeks post-stroke. Multiple regression analysis revealed significant predictors for improved dexterity at 3 and 6 months post-stroke, including younger age, higher FMA-UE score, presence of waveforms in the SEP and MEP, and higher FA values in the CST (adjusted R 2  = 0.776, P  < 0.001 at 3 months; adjusted R 2  = 0.668, P  < 0.001 at 6 months; where MEP, SEP, and FA accounted together for an additional 0.079 and 0.166 of variance beyond age and FMA-UE, respectively). Subgroup analysis was conducted by categorizing the participants based on their initial hand function: those with no hand function (MFT hand subscore = 0) (N = 60) and those with a score >0 (N = 51). Initial FMA-UE was a primary predictive factor regardless of the time point or initial severity, whereas the presence of MEP was a significant predictor only in the group with no initial hand dexterity.


Asunto(s)
Rehabilitación de Accidente Cerebrovascular , Accidente Cerebrovascular , Humanos , Neuroimagen , Recuperación de la Función/fisiología , Estudios Retrospectivos , Accidente Cerebrovascular/diagnóstico por imagen , Rehabilitación de Accidente Cerebrovascular/métodos , Extremidad Superior
5.
Anticancer Res ; 29(1): 355-62, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19331173

RESUMEN

Resveratrol, a grape polyphenol, is thought to have anti-inflammatory, cardioprotective, and cancer preventive properties. However, the mechanisms by which resveratrol might produce these effects are not clearly defined. A study was performed on whether resveratrol could prevent tumor cells from adhering to endothelial cells, which is an essential step during tumor metastasis. Phorbol 12-myristate 13-acetate (PMA) induced human fibrosarcoma HT1080 cells to adhere to endothelial ECV304 cells. Resveratrol inhibited PMA-induced HT1080 cells adhesion in a dose-dependent manner. To further study the mechanisms of this resveratrol-mediated blockade of tumor cell adhesion, the expression of the cell adhesion molecules intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin were examined. PMA induced ICAM-1 expression in HT1080 cells. In contrast, the expression of VCAM-1 and E-selectin were not altered by PMA treatment. The increase in tumor cell adhesion to endothelial cells following PMA treatment was partially inhibited by ICAM-1 siRNA or neutralizing antibodies. Resveratrol reduced the PMA-induced ICAM-1 expression in HT1080 cells as determined by RT-PCR, flow cytometry and ELISA. As the induction of ICAM-1 requires activation of the transcription factor NF-kappaB, the effects of resveratrol on the activation of this factor in HT1080 cells was also investigated. Resveratrol inhibited the PMA-induced NF-kappaB activation and NF-kappaB-dependent luciferase activity. These results suggest that resveratrol may exert an antimetastatic effect by inhibiting NF-kappaB activation and ICAM-1 expression, leading to suppression of tumor cell adhesion to endothelial cells.


Asunto(s)
Adhesión Celular/efectos de los fármacos , Células Endoteliales/efectos de los fármacos , Fibrosarcoma/patología , Molécula 1 de Adhesión Intercelular/biosíntesis , Estilbenos/farmacología , Relación Dosis-Respuesta a Droga , Células Endoteliales/metabolismo , Células Endoteliales/patología , Fibrosarcoma/tratamiento farmacológico , Fibrosarcoma/metabolismo , Humanos , Molécula 1 de Adhesión Intercelular/genética , FN-kappa B/antagonistas & inhibidores , FN-kappa B/metabolismo , ARN Interferente Pequeño/genética , Resveratrol , Acetato de Tetradecanoilforbol/farmacología , Transfección
6.
Psychiatry Clin Neurosci ; 62(1): 75-83, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18289144

RESUMEN

AIMS: The purpose of the present paper was to evaluate the effectiveness of mirtazapine orally disintegrating tablets for nausea and sleep disturbance, which are common and distressing symptoms of cancer. METHODS: This was a 4-week, prospective, open-labeled study of cancer patients. Assessments were performed at baseline and on days 1, 3, 5, 7, 14, and 28. Primary outcome measures were the Clinical Global Impression scale for nausea/vomiting and the Chonnam National University Hospital-Leeds Sleep Evaluation Questionnaire (C-LSEQ) including total amount of night sleep time. The secondary outcome measures consisted of pain items in the 36-item Short Form Health Survey, the Montgomery-Asberg Depression Rating Scale (MADRS), and the EuroQoL (EQ)-5D. Forty-two cancer patients were enrolled. RESULTS: Those with nausea (n = 28) improved significantly from day 1. The total night sleep time and each item on the C-LSEQ improved from days 1-5. The scores on the MADRS and the depression/anxiety dimension and visual analog scale of EQ-5D improved significantly from the first week. Pain measures also improved from day 1. Exacerbation of sleepiness developed in approximately one-third of subjects during the initial few days, but disappeared gradually. CONCLUSION: In the present study mirtazapine rapidly improved nausea, sleep disturbance, pain and quality of life, as well as depression in cancer patients. Mirtazapine may be an effective treatment option in managing cancer patients with multiple distressing symptoms, including nausea and sleep disturbance.


Asunto(s)
Trastornos de Adaptación/tratamiento farmacológico , Antidepresivos Tricíclicos/uso terapéutico , Trastorno Depresivo Mayor/tratamiento farmacológico , Trastorno Depresivo/tratamiento farmacológico , Mianserina/análogos & derivados , Náusea/tratamiento farmacológico , Neoplasias/psicología , Rol del Enfermo , Trastornos del Inicio y del Mantenimiento del Sueño/tratamiento farmacológico , Trastornos de Adaptación/psicología , Administración Oral , Adulto , Anciano , Antidepresivos Tricíclicos/efectos adversos , Trastorno Depresivo/psicología , Trastorno Depresivo Mayor/psicología , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Masculino , Mianserina/efectos adversos , Mianserina/uso terapéutico , Persona de Mediana Edad , Mirtazapina , Náusea/psicología , Estudios Prospectivos , Trastornos del Inicio y del Mantenimiento del Sueño/psicología , Resultado del Tratamiento
8.
Prog Neuropsychopharmacol Biol Psychiatry ; 31(2): 543-5, 2007 Mar 30.
Artículo en Inglés | MEDLINE | ID: mdl-17110011

RESUMEN

Data on the use of long-acting injectable (LAI) risperidone, the first atypical depot antipsychotic, during pregnancy are limited. A 35-year-old woman with schizophrenia was given LAI risperidone before and throughout her pregnancy. She gave birth to a female infant weighing 2230 g at 36 weeks and 6 days of pregnancy, following premature rupture of the membranes. The baby had no congenital malformation and was healthy 8 months postnatal. To our knowledge, this is the first reported use of LAI risperidone throughout an entire pregnancy. In this paper, we discuss the rationale and problems of LAI risperidone use in pregnancy, based on a literature review.


Asunto(s)
Antipsicóticos/administración & dosificación , Risperidona/administración & dosificación , Esquizofrenia/tratamiento farmacológico , Adulto , Esquema de Medicación , Femenino , Humanos , Inyecciones/métodos , Embarazo
9.
Surg Laparosc Endosc Percutan Tech ; 18(4): 417-9, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18716548

RESUMEN

An internal hernia associated with intra-abdominal blood vessels after a pelvic lymphadenectomy is very rare; to our knowledge, only 1 case has been reported to date. We report a case of a strangulated internal hernia of the small bowel behind the external iliac artery that occurred 3 months after a laparoscopic pelvic lymphadenectomy in a patient with cervical cancer. Retroperitonealization after the pelvic lymphadenectomy should be considered in patients with tortuous, elongated external iliac arteries that could be causal lesions of an internal hernia.


Asunto(s)
Hernia Ventral/etiología , Hernia Ventral/patología , Histerectomía/efectos adversos , Laparoscopía/efectos adversos , Escisión del Ganglio Linfático/efectos adversos , Neoplasias del Cuello Uterino/cirugía , Anciano , Femenino , Gangrena/etiología , Gangrena/patología , Gangrena/cirugía , Hernia Ventral/cirugía , Humanos , Arteria Ilíaca , Pelvis
10.
J Obstet Gynaecol Res ; 34(4 Pt 2): 641-4, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18840171

RESUMEN

Hydatidiform mole with a coexistent fetus is rare, but this condition has recently shown an increased incidence because of assisted reproduction technology. Herein, we report on a case of triplet pregnancy with a partial hydatidiform mole coexisting with two fetuses. It was diagnosed by p57(kip2) immunohistochemical staining which is helpful in determining histologically equivocal cases. After termination of pregnancy, the patient was diagnosed with persistent gestational trophoblastic disease. Six courses of methotrexate chemotherapy were performed. Her beta-human chorionic gonadotrophin titers then fell to a normal level.


Asunto(s)
Mola Hidatiforme/diagnóstico , Embarazo Múltiple , Neoplasias Uterinas/diagnóstico , Adulto , Biomarcadores/metabolismo , Inhibidor p57 de las Quinasas Dependientes de la Ciclina/metabolismo , Femenino , Humanos , Mola Hidatiforme/metabolismo , Embarazo , Neoplasias Uterinas/metabolismo
11.
J Korean Med Sci ; 22(2): 357-61, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17449950

RESUMEN

Although congenital renal tumors are rare, congenital mesoblastic nephroma (CMN) is the most common renal tumor in early infancy. It is non-metastatic, well differentiated, amenable to surgical removal, and carries a good prognosis. Polyhydramnios has been detected in most of the published cases of CMN. However, we experienced a rare case of fetal CMN associated with oligohydramnios. A 28-yr old woman at 34 weeks of gestation was referred to our hospital for oligohydramnios and a fetal abdominal mass. An ultrasonography revealed a huge, well-encapsulated mass arising from the right kidney. An emergency cesarean section was performed due to fetal distress. After birth, despite intensive neonatal care, the baby died because of renal failure, disseminated intravascular coagulopathy, pulmonary edema, together with other problems.


Asunto(s)
Neoplasias Renales/diagnóstico , Nefroma Mesoblástico/diagnóstico , Oligohidramnios/diagnóstico , Adulto , Cesárea , Resultado Fatal , Femenino , Enfermedades Fetales/etiología , Enfermedades Fetales/prevención & control , Humanos , Recién Nacido , Neoplasias Renales/terapia , Nefroma Mesoblástico/terapia , Oligohidramnios/terapia , Embarazo
12.
Cancer Res Treat ; 38(2): 108-11, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19771268

RESUMEN

PURPOSE: It is well known that human papillomavirus (HPV) is the main cause of cervical neoplasia, and hydrogen peroxide-producing lactobacilli are the most important microorganisms for maintaining the balance of the vaginal ecosystem. The purpose of our study was to investigate the relationship of hydrogen peroxide-producing lactobacilli, cervical neoplasia and high-risk HPV. MATERIALS AND METHODS: We enrolled 1138 women with abnormal cervical smears or cervicograms who were referred to the department of Obstetrics and Gynecology at Chonnam National University Medical School. In all of them, 1,138 vaginal swabs were collected for the qualitative assay of hydrogen peroxide producing lactobacilli and 150 cervical swabs were used for the HPV hybrid capture II test without regard to the subjects' pregnancy status. In the non-pregnant women, 880 cervical biopsies and/or loop electrosurgical excision procedures were performed for making the histological diagnosis. RESULTS: There was no significant difference not only between the distribution of H(2)O(2) producing lactobacilli and the cervical histology, but also between the distribution of H(2)O(2) producing lactobacilli and the positivity for high-risk HPV. CONCLUSIONS: Both cervical neoplasia and high-risk HPV may not be influenced by the existence of hydrogen peroxide producing lactobacilli in the vagina.

13.
J Obstet Gynaecol Res ; 32(1): 32-41, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16445523

RESUMEN

AIM: Our purpose was to investigate lipid peroxide levels, total peroxyl radical-trapping anti-oxidative parameter (TRAP) values, and anti-oxidant vitamin levels in umbilical venous plasma and placental tissues, and to evaluate their roles in the pathophysiology of pre-eclampsia. METHODS: Samples of umbilical venous plasma and placental tissue homogenates were obtained from 23 normal and 18 pre-eclamptic women at between 33 and 40 weeks' gestation. The enzyme-linked immunosorbent assay method was used to assay alpha-tumor necrosis factor (TNF-alpha), and lipid peroxide levels were measured by thiobarbituric acid reaction. The TRAP values were measured using the modified Wayner's method. Ascorbic acid, retinol alpha-tocopherol and gamma-tocopherol were measured by high performance liquid chromatography. RESULTS: Levels of TNF-alpha in placental tissue homogenates of women with pre-eclampsia were significantly higher than those of women with normal pregnancy (21.4 +/- 3.39 v. 10.3 +/- 1.06 pg/mL, P < 0.05). Lipid peroxide levels in umbilical venous plasma and placental tissue homogenates of women with pre-eclampsia were significantly higher than those of women with normal pregnancy (10.3 +/- 1.1 v. 5.85 +/- 0.53, P < 0.01, 5.14 +/- 0.40 v. 3.99 +/- 0.33 nmol/mg protein, P < 0.05, respectively). The TRAP values in umbilical venous plasma and placental tissue homogenates of women with pre-eclampsia were significantly lower than those of women with normal pregnancy (0.39 +/- 0.02 v. 0.45 +/- 0.02, P < 0.05, 0.27 +/- 0.02 v. 0.34 +/- 0.03 mM, P < 0.05, respectively). Ascorbic acid levels in umbilical venous plasma and placental tissue homogenates of women with pre-eclampsia were significantly lower than those of women with normal pregnancy (325.4 +/- 50.4 v. 543 +/- 73.8, P < 0.05, 219.0 +/- 21.0 v. 333.3 +/- 32.6 nmol/mL, P < 0.05, respectively). CONCLUSIONS: The above results suggest that increased oxidative stress in the placenta is involved in the pathophysiology of pre-eclampsia, and ascorbic acid may act as an important preventative factor in the development of pre-eclampsia.


Asunto(s)
Antioxidantes/metabolismo , Placenta/metabolismo , Preeclampsia/metabolismo , Adulto , Estudios de Casos y Controles , Femenino , Humanos , Peróxidos Lipídicos/sangre , Peróxidos Lipídicos/metabolismo , Peróxidos/metabolismo , Embarazo , Factor de Necrosis Tumoral alfa/metabolismo , Cordón Umbilical/irrigación sanguínea
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA